Back to search
Primary Gout and Hyperuricemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Gout and Hyperuricemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Gout and Hyperuricemia trials you may qualify forSHR4640 tablets is a highly selective and potent URAT1 inhibitors. The study is being conducted to evaluate the efficacy, and safety of SHR4640 tablet combined…
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
This study is a randomized, double-blind, non-befloxacin-controlled, multicenter, phase II clinical trial, evaluating the efficacy, safety, and pharmacokinetic…
The aim of this 6-month randomized multi-regional double-blind parallel group placebo-controlled phase 3 study is to assess the efficacy and safety of three dif…
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and sa…